THERAPEUTIC TECHNOLOGY IN DEVELOPMENT
NeoBoost
Photonic biostimulation for the neonatal respiratory challenge.
A technology in development exploring the controlled application of near-infrared light to stimulate the newborn’s own pulmonary mechanisms.
Conceptual representation of the technology in development. The illustrated elements and values are not final specifications.
Conceptual representation of the technology in development. It does not depict commercial equipment.
THE CHALLENGE
When the lungs are not yet ready to breathe.
Neonatal respiratory distress syndrome is strongly associated with prematurity and a deficiency of pulmonary surfactant, a substance that helps keep the alveoli open during breathing.
Prematurity
Pulmonary immaturity.
Surfactant deficiency
Reduced alveolar stability.
Alveolar collapse
Difficulty keeping the alveoli open.
Need for respiratory support
Ventilation support during the critical period.
A NEW APPROACH UNDER INVESTIGATION
Stimulating the newborn’s own pulmonary mechanisms.
NeoBoost investigates photonic biostimulation with NIR light to stimulate endogenous surfactant production and modulate pulmonary inflammatory processes.
Mechanism under investigation. This representation does not demonstrate clinical efficacy.
NIR light
Light applied to the chest tissues, directed at the pulmonary region.
Type II pneumocytes
Research explores the interaction of light with mitochondria and the stimulation of cellular activity.
Inflammatory modulation
Exploring the modulation of pulmonary inflammatory processes.
Surfactant production
Aiming to stimulate endogenous surfactant production.
THERAPY, MONITORING AND CONTROL
Light is just one part of the system.
In its concept under development, NeoBoost combines controlled NIR light application, TD-NIRS optical monitoring and adaptive control of application parameters.
01
Apply
Controlled delivery of NIR light
Flexible applicators designed for bilateral placement on the chest.
02
Measure
TD-NIRS optical monitoring
The temporal response of photons provides information about light propagation through tissues.
03
Adapt
Control of application parameters
The concept envisages using the collected information to dynamically adjust the intensity, duration and dose of application.
CLOSED-LOOP CONTROL SYSTEM
Conceptual representations of the technology in development. The illustrated values are not final specifications.
DESIGNED FOR NEONATAL SETTINGS
Technology designed for the realities of neonatal units.
A system in development, designed to integrate application, monitoring and control in neonatal settings.
Flexible applicators
Designed to adapt to the neonatal chest.
Thermal monitoring
The concept envisages tracking temperature during application.
Real-time control
The architecture includes a display of the main session parameters.
Integrated architecture
Applicators, optical monitoring and control unit designed as a single system.
DEVELOPMENT
From technological principle to clinical validation.
NeoBoost is in development. Research focuses on understanding and validating the controlled application of photonic biostimulation in the neonatal respiratory context.
Confirmed current status
Research objective
Research focused on the controlled application of NIR light in neonatal settings.
A FUTURE WITH MORE POSSIBILITIES
Developing new possibilities for neonatal respiratory care.
NeoBoost is part of BirthTech’s research into therapeutic technologies for the first moments of life.